New bladder pain drug shows promise in early trial

NCT ID NCT06394830

Recruiting now Symptom relief Sponsor: Vaneltix Pharma, Inc. Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 10, 2026 · Updated 28 times

Summary

This study tests a drug called VNX001 for people with Interstitial Cystitis (a condition causing bladder pain) who have sudden, moderate-to-severe pain. About 50 adults will receive up to 6 doses of the drug through a catheter over 14 days. The goal is to see if the drug safely reduces pain and how often it is needed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERSTITIAL CYSTITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Arizona Urology Specialists
COMPLETED

Tucson, Arizona, 85715, United States
Georgia Urology
RECRUITING

Cartersville, Georgia, 30120, United States
Oregon Urology Institute
RECRUITING

Springfield, Oregon, 97477, United States
Prestige Medical Group
SUSPENDED

Tustin, California, 92780, United States
Valley Urology, Inc.
SUSPENDED

Fresno, California, 93710, United States

Conditions

Explore the condition pages connected to this study.

BLADDER PAIN SYNDROME INTERSTITIAL CYSTITIS